Literature DB >> 18959824

Aldosterone and CKD in metabolic syndrome.

Toshiro Fujita1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18959824     DOI： 10.1007/s11906-008-0078-y

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   5.369


× No keyword cloud information.
  13 in total

1.  Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker.

Authors:  Miki Nagase; Shigeru Shibata; Shigetaka Yoshida; Takashi Nagase; Takanari Gotoda; Toshiro Fujita
Journal:  Hypertension       Date:  2006-04-24       Impact factor: 10.190

Review 2.  Is aldosterone bad for the heart?

Authors:  John W Funder
Journal:  Trends Endocrinol Metab       Date:  2004 May-Jun       Impact factor: 12.015

3.  Plasma aldosterone is independently associated with the metabolic syndrome.

Authors:  Murielle Bochud; Jürg Nussberger; Pascal Bovet; Marc R Maillard; Robert C Elston; Fred Paccaud; Conrad Shamlaye; Michel Burnier
Journal:  Hypertension       Date:  2006-06-19       Impact factor: 10.190

4.  Regulation of SUMOylation by reversible oxidation of SUMO conjugating enzymes.

Authors:  Guillaume Bossis; Frauke Melchior
Journal:  Mol Cell       Date:  2006-02-03       Impact factor: 17.970

5.  Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors.

Authors:  Miki Nagase; Shigetaka Yoshida; Shigeru Shibata; Takashi Nagase; Takanari Gotoda; Katsuyuki Ando; Toshiro Fujita
Journal:  J Am Soc Nephrol       Date:  2006-11-02       Impact factor: 10.121

6.  Urinary excretion of 8-oxo-7, 8-dihydro-2'-deoxyguanosine as a predictor of the development of diabetic nephropathy.

Authors:  Y Hinokio; S Suzuki; M Hirai; C Suzuki; M Suzuki; T Toyota
Journal:  Diabetologia       Date:  2002-05-08       Impact factor: 10.122

Review 7.  Effect of aldosterone blockade in patients with systolic left ventricular dysfunction: implications of the RALES and EPHESUS studies.

Authors:  Bertram Pitt
Journal:  Mol Cell Endocrinol       Date:  2004-03-31       Impact factor: 4.102

8.  The metabolic syndrome and chronic kidney disease in U.S. adults.

Authors:  Jing Chen; Paul Muntner; L Lee Hamm; Daniel W Jones; Vecihi Batuman; Vivian Fonseca; Paul K Whelton; Jiang He
Journal:  Ann Intern Med       Date:  2004-02-03       Impact factor: 25.391

9.  Salt excess causes left ventricular diastolic dysfunction in rats with metabolic disorder.

Authors:  Hiromitsu Matsui; Katsuyuki Ando; Hiroo Kawarazaki; Ai Nagae; Megumi Fujita; Tatsuo Shimosawa; Miki Nagase; Toshiro Fujita
Journal:  Hypertension       Date:  2008-07-07       Impact factor: 10.190

10.  Human adipocytes secrete mineralocorticoid-releasing factors.

Authors:  M Ehrhart-Bornstein; V Lamounier-Zepter; A Schraven; J Langenbach; H S Willenberg; A Barthel; H Hauner; S M McCann; W A Scherbaum; S R Bornstein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-12       Impact factor: 11.205
View more
  1 in total

Review 1.  The necessity and effectiveness of mineralocorticoid receptor antagonist in the treatment of diabetic nephropathy.

Authors:  Atsuhisa Sato
Journal:  Hypertens Res       Date:  2015-03-12       Impact factor: 3.872
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.